Mosaic signs license agreement covering use of cowpea mosaic virus to treat cancer May 6, 2022 No Comments
Turning Point and LaNova enter license agreement for LM-302 and collaboration on ADC programs May 6, 2022 No Comments
ProfoundBio antibody-drug conjugate PRO-1102 shows potency in vitro and in vivo May 3, 2022 No Comments
Gilead and Dragonfly collaborate to advance NK cell engager-based immunotherapies May 3, 2022 No Comments
Allogeneic colorectal cancer vaccine active against anti-PD-1-resistant colon cancer May 3, 2022 No Comments
Chimera Bioengineering advances preclinical testing of CAR-T therapy CBIO-007 for solid tumors April 29, 2022 No Comments
Allogeneic NK-cell therapy CAT-179 useful for controlling HER2-positive tumors April 28, 2022 No Comments
RSS